296 related articles for article (PubMed ID: 34947049)
1. A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Feys S; Almyroudi MP; Braspenning R; Lagrou K; Spriet I; Dimopoulos G; Wauters J
J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947049
[TBL] [Abstract][Full Text] [Related]
2. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
[TBL] [Abstract][Full Text] [Related]
4. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
[TBL] [Abstract][Full Text] [Related]
5. Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
Reizine F; Pinceaux K; Lederlin M; Autier B; Guegan H; Gacouin A; Luque-Paz D; Boglione-Kerrien C; Bacle A; Le Daré B; Launey Y; Lesouhaitier M; Painvin B; Camus C; Mansour A; Robert-Gangneux F; Belaz S; Le Tulzo Y; Tadié JM; Maamar A; Gangneux JP
J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34063556
[TBL] [Abstract][Full Text] [Related]
6. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
[TBL] [Abstract][Full Text] [Related]
7. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
[TBL] [Abstract][Full Text] [Related]
8. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
[TBL] [Abstract][Full Text] [Related]
9. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP
J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176
[TBL] [Abstract][Full Text] [Related]
10. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
[TBL] [Abstract][Full Text] [Related]
13. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
14. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
15. Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients.
Peral J; Estella Á; Nuvials X; Rodríguez A; Seijas I; Soriano C; Suberviola B; Zaragoza R
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983480
[TBL] [Abstract][Full Text] [Related]
16. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
[TBL] [Abstract][Full Text] [Related]
18. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
[TBL] [Abstract][Full Text] [Related]
19. Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data.
Casalini G; Giacomelli A; Galimberti L; Colombo R; Ballone E; Pozza G; Zacheo M; Galimberti M; Oreni L; Carsana L; Longo M; Gismondo MR; Tonello C; Nebuloni M; Antinori S
J Fungi (Basel); 2022 Aug; 8(9):. PubMed ID: 36135619
[TBL] [Abstract][Full Text] [Related]
20. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
